Thyroid cancer review 2: management of differentiated thyroid cancers.
This is the second review article on thyroid cancer dealing with the common differentiated types that comprise 90% of thyroid cancers. Despite clinical management guidelines offered by a number of organisations including the British Association of Otolaryngologists and Head and Neck Surgeon, The British Thyroid Association, The American Association Of Endocrinologists, The American Thyroid Association and the National Cancer Centre Network, debate regarding the management of differentiated thyroid cancer continues. This is because of the absence of good quality research evidence as a consequence of the natural history of this disease.
Nix
P
P
Department of Otolaryngology, Head and Neck Surgery, York, UK.
Nicolaides
A
A
Coatesworth
A P
AP
D002291:Carcinoma, Papillary / Q000628:therapy*; D018265:Carcinoma, Papillary, Follicular / Q000628:therapy*; D006801:Humans; D007037:Hypothyroidism / Q000517:prevention & control; D009333:Neck / Q000601:surgery; D013964:Thyroid Neoplasms / Q000628:therapy*; D013965:Thyroidectomy / Q000009:adverse effects / Q000379:methods; D013974:Thyroxine / Q000627:therapeutic use
D013974:Thyroxine